Suptavumab: A Deep Dive into the REGN2222 Monoclonal Antibody REGN2222 is a engineered antibody created to selectively bind IL-18 , a key cytokine involved in significant respiratory syndrome syndrome https://www.targetmol.com/compound/suptavumab